This study also provides the first demonstration that URGCP is a positive regulator of tumor growth in glioma, while, knockdown of URGCP effectively suppresses cell proliferative activity and tumor growth via inhibiting the G1/S transition. Here, URGCP is linked to central nervous system cancer.